About: BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. The company is headquartered in West Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.06 (-3.16%)
BCTX NASDAQ Briacell Therapeutics Corp
Briacell Therapeutics Corp share price
Atividade de preço de BCTX
Último preço
$ 3,060
Variação (24h)
-0,10 USD (3,16%)
Volume
108.30K
Volume (média 4 sem.)
-
Abertura
$ 3,14
Variação do dia
$ 3,02 - $ 3,20
Fechamento anterior
$ 3,16
Último negócio
20 Nov, 9:00 pm GMT+0
Atrasado
20 Nov, 9:00 pm GMT+0
BCTX price performance
Atrasado
20 Nov, 9:00 pm GMT+0
BCTX details
quote.marketSignals